Key Drivers
- Margin recovery
- Solid liquidity
- Earnings weakness
AIAI Summary
ICUI has shifted from a “cleanup” story to a real operating-improvement case, with 6% organic growth, expanding margins, and strong cash flow supporting the thesis, but the stock's rerating means the key test now is whether it can sustain this momentum through the Austin expansion and keep holding the 170-172 breakout zone.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin recovery
- •Solid liquidity
- •Earnings weakness
ICUI shows improving recent margins and solid liquidity/cash flow, but thin annual profits, modest leverage, and an earnings-based valuation that is still expensive keep the investment case mixed.
Price Behavior
Key Price Behavior Insights:
- •Higher highs
- •Breakout hold
- •Extended rally
ICUI has turned bullish over the last month after breaking above the $170-$172 resistance zone and holding near $183, though the fast rally makes a short-term pause or pullback possible.
Sharp jump on 2026-08-07 suggests near-term volatility risk
Sentiment & News
Key News Insights:
- •Earnings beat
- •Guidance raised
- •Stake increased
ICU Medical beat Q2 expectations with $548 million in revenue and $2.37 adjusted EPS, raised fiscal 2026 guidance, and drew more bullish analyst and institutional interest.
The stronger-than-expected quarter and improved outlook are likely supportive for ICU Medical shares in the near term
Similar Companies in Healthcare
Other companies in the same sector with AI ratings